Awareness of opioid risks, policies is important for NPs

06/21/2013 | ClinicalAdvisor.com

Familiarity with the FDA's risk evaluation and mitigation strategies for extended-release and long-acting opioids is important even for nurse practitioners who do not prescribe those drugs, experts said at the AANP National Conference in Las Vegas. "You may not be prescribing opioids to your patients, but another health care provider may be, or they could be getting them from another patient. Friends and family are the biggest source of opioid pain pills, either as gifts or through theft," nurse practitioner and pain management specialist Deborah Kiley said.

View Full Article in:

ClinicalAdvisor.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT